Drug ‘slows growth of breast cancer tumour’

Cancer Research UK scientists have found a new way to slow the growth of the most aggressive type of breast cancer. The team from Oxford University and the University of Nottingham found that using a...

New class of drugs could help tackle treatment-resistant cancers

Researchers have discovered a new class of drug that has the potential to help cancer patients who no longer respond to existing therapies. The drug may not become available to patients for a number of...

UK’s unique national pancreas tissue bank opens for business

The UK’s national tissue bank for pancreatic diseases is open for applications from any UK-based researchers needing samples of blood, urine and saliva to aid their research. The Pancreatic Cancer Research Fund Tissue Bank (PCRF...

Parkinson’s unique scent

Scientists at The University of Manchester have found small molecules contained in a substance secreted by the skin, known as sebum, that are responsible for a unique scent in people with Parkinson’s. The results could...

Research centres are confirmed

Two Cambridge institutes have been confirmed as major research centres by biomedical research charity Wellcome. The Wellcome/CRUK Gurdon Institute and Wellcome/MRC Cambridge Stem Cell Institute have been named as two of 14 Wellcome Centres which...

Directing’ evolution to identify potential drugs earlier in discovery

Scientists have developed a technique that could significantly reduce the time to discover potential new antibody-based drugs to treat disease. Antibodies are produced by the body in response to the presence of a disease-causing agent....

Cracking the code could be key to tackling infections

Researchers have made a major breakthrough in tackling infections caused by a major group of viruses including the common cold and polio. The team has cracked a code hidden in the sequence of the ribonucleic...

Enzyme research

Scientists at the University of York were part of a research team which found that a recently-discovered family of enzymes can degrade resistant forms of starch. Earlier research established that the enzymes – lytic polysaccharide...

Connect 2 Cleanrooms and RoslinCT partner to introduce new GMP Cell and Gene Therapy...

Connect 2 Cleanrooms (C2C), in partnership with RoslinCT, is pleased to present the new state-of-the-art GMP manufacturing facility and training laboratory at RoslinCT’s BioCube building in Edinburgh’s BioQuarter. RoslinCT is a cell therapy Contract Development...

UK adults differ from NHS England boss on health priorities

A recent poll shows UK adults believe dementia is in the top three health areas the NHS should focus on in the next 10 years. The survey commissioned by Alzheimer’s Research UK shows starkly...

New bacterial strain named after Cornish discovery

A new bacterial strain will be named after Cornwall following its identification from a skin infection. Staphylococcus cornubiensis, named after the medieval name for Cornwall, Cornubia, was isolated from a sample submitted to the laboratory...

Wellcome launches £250m Leap Fund to place big bets on bold research

Wellcome is to launch a new £250m fund that will place big bets on ambitious research programmes with the potential to fundamentally change science or transform health over a five- to ten-year horizon. The Wellcome...

Rare tick-borne infections diagnosed

Public Health England has confirmed the diagnosis of a case of babesiosis and a probable case of tick-borne encephalitis in England. This is the first record of a UK-acquired case of babesiosis and the second...

Connect 2 Cleanrooms delivers solid-state battery production cleanroom for Ilika

Connect 2 Cleanrooms Ltd (C2C) has completed a new 340m2 cleanroom facility for Ilika PLC at its 1600m2 Stereax—millimetre-scale solid-state batteries—manufacturing facility. The cleanroom is a key element of Ilika’s new facility as it scales up Stereax, to become the first volume manufacturer...

Targetting fast-growing cancer cells

The discovery that an essential protein plays a protective role during cell division, could open the door to better targeted treatment of fast-growing cancer cells. Polo-like kinase (PLK1) was previously thought to have a major...

Medicines Discovery Catapult appoints new Chair as it moves into the next phase of...

Medicines Discovery Catapult has appointed Dr Robin Brown as its new Chairman.  The company has established itself rapidly within the UK community and is now engaged in multiple R&D collaborations with UK biotech and...